Search Results

You are looking at 81 - 90 of 168 items for :

  • All content x
Clear All
Full access

Yuan-Yuan Lei, Suzanne C. Ho, Ashley Cheng, Carol Kwok, Chi-Kiu Iris Lee, Ka Li Cheung, Roselle Lee, Herbert H.F. Loong, Yi-Qian He, and Winnie Yeo

Cancer Staging Manual , 7th ed. New York, NY : Springer ; 2010 . 26. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment . Available at: http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf . Accessed

Full access

Karam Khaddour, Michael R. Chicoine, Jiayi Huang, Sonika Dahiya, and George Ansstas

from surgery and RT can lead to substantially impaired quality of life, including visual defects, epilepsy, hypopituitarism, diabetes insipidus, hypothalamic obesity, and other neurologic deficits. 8 For example, in a series of 123 patients with

Full access

Kaylene Ready and Banu Arun

hyperplasia [ADH], atypical lobular hyperplasia [ALH], lobular carcinoma in situ [LCIS]), age at menarche, parity, breast feeding, diethylstilbestrol (DES) exposure, early breast radiation, hormone replacement therapy, obesity, alcohol intake, family history

Full access

Crystal S. Denlinger, Robert W. Carlson, Madhuri Are, K. Scott Baker, Elizabeth Davis, Stephen B. Edge, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Elizabeth Kvale, Terry S. Langbaum, Jennifer A. Ligibel, Mary S. McCabe, Kevin T. McVary, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Tracey O’Connor, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian, and Deborah Freedman-Cass

(especially hormone therapy, narcotics, and serotonin reuptake receptor inhibitors) that could be a contributing factor. Traditional risk factors for sexual dysfunction, such as cardiovascular disease, diabetes, obesity, smoking, and alcohol abuse, should also

Full access

Nishant Patel, Adam C. Yopp, and Amit G. Singal

other. NAFLD was often associated with components of the metabolic syndrome (obesity, diabetes, dyslipidemia) but was a diagnosis of exclusion, only made in the absence of other causes of liver disease, including viral hepatitis and alcohol abuse

Full access

Chloe E. Atreya, Eric A. Collisson, Meyeon Park, James P. Grenert, Spencer C. Behr, Amalia Gonzalez, Jonathan Chou, Samantha Maisel, Terence W. Friedlander, Chris E. Freise, Jun Shoji, Thomas J. Semrad, Jessica Van Ziffle, and Peter Chin-Hong

transmission at between 0.01% and 0.05% per solid organ transplant. 8 , 9 This risk may be increasing along with donor age and obesity. Meanwhile, there is an ongoing concern for underreporting—and importantly, underdetection—because the etiology of cancer in

Full access

Arjun Gupta, Avash Das, Raseen Tariq, Nizar Bhulani, Naveen Premnath, Dipesh Solanky, Ryan D. Frank, David Johnson, Sahil Khanna, and Muhammad S. Beg

complications, hypertension, liver disease, and obesity were identified using ICD-9-CM diagnosis codes and diagnosis-related group codes. They were assessed using the Charlson comorbidity index. Patients with heart failure and stroke undergoing intubation

Full access

Michael J. Hassett, Wei Jiang, Melissa E. Hughes, Stephen Edge, Sara H. Javid, Joyce C. Niland, Richard Theriault, Yu-Ning Wong, Deborah Schrag, and Rinaa S. Punglia

one-third were age >60 years at diagnosis, 16% were non-white/Hispanic, almost half were overweight/obese (body mass index ≥25 kg/m 2 ), and one-quarter had a comorbidity score ≥1 ( Table 1 ). Infrequently, the initial DCIS was large (≥2 cm in 10%) or

Full access

Kuan-Ling Kuo, David Stenehjem, Frederick Albright, Saurabh Ray, and Diana Brixner

. 3 Other risk factors for HCC include heavy alcohol use, Asian race, male sex with confirmed heritable metabolic diseases (Wilson disease, porphyria cutanea tarda, alpha-1 antitrypsin deficiency, tyrosinemia, and glycogen storage diseases), obesity

Full access

Simon D. Fung-Kee-Fung, Sima P. Porten, Maxwell V. Meng, and Michael Kuettel

with regard to men undergoing RP. Factors that affected overall patient-reported outcomes were large prostate size, obesity, older age, black race, and a high pretreatment PSA. Adjuvant androgen deprivation in the radiation treatment groups exacerbated